Boardroom Alpha
Start trial
10-Q primary document
MDB · Quarterly Report (Form 10-Q) · Filed December 2, 2025

Mongodb Inc — 10-Q exhibit

a2025-10x29xex102offerle.htm
Mongodb Inc on Boardroom Alpha
a2025-10x29xex102offerle
​October 29, 2025​ ​Chirantan J. Desai​ ​[via email]​ ​Dear CJ,​ ​MongoDB,​​Inc.​​(the​​“Company”)​​is​​delighted​​to​​confirm​​our​​employment​​offer​​for​​the​​position​​of​​President​​and​​Chief​ ​Executive​ ​Officer​ ​to​ ​be​​based​​in​​our​​New​​York​​and​​Palo​​Alto​​offices​​(with​​travel​​to​​other​​offices​​from​​time​​to​​time),​ ​reporting​​to​​the​​Company’s​​Board​​of​​Directors​​(the​​“Board”).​ ​You​​will​ ​also​​be​​appointed​​to​​the​​Company’s​​Board​​as​ ​an​ ​executive​ ​member​ ​of​ ​the​ ​Board.​ ​If​ ​you​ ​accept​ ​our​ ​offer,​ ​the​ ​terms​ ​and​ ​conditions​ ​set​ ​forth​ ​in​ ​this​ ​offer​ ​letter​ ​agreement​​(the​​“Agreement”)​​will​ ​become​​effective​​as​​of​​November​​10,​​2025​​or​​later​​date​​mutually​​agreed​​with​​the​ ​Company (the “Effective Date”).​ ​Base Salary​ ​You​​will​ ​be​​employed​​as​​a​​full-time​​salaried​​employee,​​compensated​​at​​the​​rate​​of​​$20,833.33​​per​​semi-monthly​​pay​ ​period​​($500,000​​annually).​​Currently,​​the​​Company’s​​regular​​pay​​dates​​are​​the​​15th​​and​​last​​day​​of​​each​​calendar​ ​month.​​If​​a​​pay​​date​​falls​​on​​a​​weekend​​or​​Federal/bank​​holiday,​​then​​the​​pay​​date​​will​​be​​on​​the​​previous​​business​ ​day.​ ​Said​ ​salary​ ​will​ ​be​ ​paid​​in​​accordance​​with​​the​​Company’s​​normal​​payroll​​practices​​as​​may​​exist​​from​​time​​to​ ​time and is subject to required and voluntary withholdings.​ ​Bonus​ ​In​​addition​​to​​your​​base​​salary,​​during​​your​​employment​​as​​President​​and​​Chief​​Executive​​Officer,​​you​​will​​continue​​to​ ​be​​eligible​​for​​an​​annual​​bonus​​with​​a​​target​​of​​$350,000​​(or​​70%​​of​​base​​salary)​​per​​annum​​paid​​semi-annually,​​and​ ​which​ ​will​ ​be​ ​based​ ​on​ ​achievement​ ​of​​Company​​performance​​goals​​to​​be​​determined​​by​​the​​Company​​in​​its​​sole​ ​discretion.​​Bonus​​is​​subject​​to​​required​​and​​voluntary​​withholdings​​and​​paid​​according​​to​​Company​​payroll​​practices.​ ​You​ ​must​ ​be​ ​employed​ ​on​ ​the​ ​bonus​ ​payment​ ​date​ ​to​ ​be​ ​eligible​ ​for​ ​the​ ​bonus​ ​payment,​ ​except​ ​as​ ​otherwise​ ​provided below.​ ​Sign on Cash and Equity​ ​You​​will​​be​​entitled​​to​​a​​sign​​on​​bonus​​of​​$2,500,000,​​payable​​in​​cash:​​fifty​​percent​​($1,250,000)​​following​​six​​months​ ​of​​continuous​​service​​from​​the​​Effective​​Date​​and​​the​​remaining​​fifty​​percent​​($1,250,000)​​following​​twelve​​months​​of​ ​continuous​​service​​from​​the​​Effective​​Date,​​in​​each​​case,​​within​​the​​next​​applicable​​payroll​​cycle​​following​​each​​such​ ​payment vesting date.​ ​You​ ​will​ ​also​ ​be​ ​entitled​ ​to​ ​receive​ ​a​ ​Restricted​ ​Stock​ ​Unit​ ​award​ ​for​ ​shares​ ​of​ ​the​ ​Company’s​ ​Common​ ​Stock​ ​(“RSUs”)​​with​​a​​value​​as​​of​​the​​grant​​date​​of​​fifteen​​million​​US​​Dollars​​($15,000,000),​​with​​the​​number​​of​​RSUs​​to​​be​ ​determined​ ​by​ ​the​ ​Compensation​ ​Committee​ ​of​ ​the​ ​Board​ ​(the​ ​“Committee”),​ ​based​ ​on​ ​the​ ​closing​ ​price​ ​of​ ​the​ ​Company’s​ ​stock​ ​on​ ​October​ ​27,​ ​2025,​ ​subject​ ​to​ ​Committee​ ​approval​ ​and​ ​other​ ​terms​ ​and​ ​conditions​ ​of​ ​the​ ​Company’s​ ​2016​ ​Equity​ ​Incentive​ ​Plan​ ​and​ ​the​ ​related​ ​Restricted​ ​Stock​ ​Unit​ ​Award​​Grant​​Notice​​and​​Restricted​ ​Stock​​Unit​​Agreement.​​The​​RSUs​​will​ ​vest​​in​​eight​​equal​​quarterly​​installments​​over​​two​​(2)​​years​​starting​​after​​the​ ​first​ ​quarter​ ​following​ ​the​ ​Vesting​ ​Start​ ​Date​ ​(as​ ​set​ ​forth​ ​in​ ​the​ ​applicable​ ​award​ ​agreement),​ ​subject​ ​to​ ​your​ ​continuous​​service​​through​​each​​applicable​​vesting​​date​​such​​that​​100%​​of​​the​​RSUs​​will​​be​​vested​​on​​the​​two-year​ ​anniversary​​of​​the​​Vesting​​Start​​Date.​​Each​​RSU​​installment​​shall​​be​​subject​​to​​a​​one​​year​​holding​​period​​such​​that,​ ​following​​the​​vesting​​of​​each​​RSU​​installment,​​you​​agree​​not​​to​​sell,​​trade​​or​​otherwise​​dispose​​of​​such​​RSUs​​for​​an​ ​additional one year period following each such vesting date.​ Exhibit 10.2

 
​You​ ​will​ ​also​ ​be​ ​entitled​ ​to​ ​receive​​a​​Performance​​Stock​​Unit​​award​​for​​shares​​of​​the​​Company’s​​Common​​Stock​ ​(“PSUs”)​​with​​a​​value​​as​​of​​October​​27,​​2025,​​of​​seventeen​​million​​five​​hundred​​thousand​​US​​Dollars​​($17,500,000),​ ​with​​the​​number​​of​​PSUs​​to​​be​​determined​​by​​the​​Committee​​based​​on​​the​​closing​​price​​of​​the​​Company’s​​stock​​on​ ​October​​27,​​2025,​​as​​determined​​by​​the​​Committee,​​subject​​to​​Committee​​approval​​and​​other​​terms​​and​​conditions​ ​of​ ​the​ ​Company’s​ ​2016​ ​Equity​ ​Incentive​ ​Plan​ ​and​ ​the​ ​related​ ​Performance​ ​Stock​ ​Unit​ ​Award​ ​Grant​ ​Notice​ ​and​ ​Performance​ ​Stock​ ​Unit​ ​Agreement.​ ​Your​ ​grant​​will​ ​vest​​over​​three​​(3)​​years​​with​​a​​minimum​​one​​year​​time​​vest.​ ​Your​ ​grant​ ​will​ ​vest​ ​on​ ​the​ ​three​ ​year​ ​anniversary​ ​of​ ​the​ ​Vesting​ ​Start​ ​Date,​ ​subject​ ​to​ ​your​ ​continuous​ ​service​ ​through​​such​​vesting​​date,​​with​​the​​number​​of​​PSUs​​to​​be​​determined​​based​​on​​the​​Company’s​​performance​​(with​ ​such metrics as determined by the Committee).​ ​Equity​ ​You will be eligible to receive annual refresh grants based on performance.​ ​Termination​ ​Except​ ​as​ ​provided​ ​below,​ ​if​ ​you​ ​resign​ ​or​ ​the​ ​Company​ ​terminates​ ​your​ ​employment,​ ​or​ ​upon​ ​your​ ​death​ ​or​ ​disability,​​then​​(i)​​you​​will​ ​no​​longer​​vest​​in​​any​​equity​​awards,​​(ii)​​all​ ​payments​​of​​compensation​​by​​the​​Company​​to​ ​you​​hereunder​​will​ ​terminate​​immediately​​(except​​as​​to​​amounts​​already​​earned),​​and​​(iii)​​you​​will​ ​not​​be​​entitled​​to​ ​any​​severance​​benefits.​​In​​addition,​​you​​will​​resign​​from​​all​​positions​​and​​terminate​​any​​relationships​​as​​an​​employee,​ ​advisor, officer or director with the Company and any of its affiliates, each effective on the date of termination.​ ​In​ ​the​ ​event​ ​your​ ​employment​ ​with​​the​​Company​​is​​terminated​​by​​the​​Company​​without​​Cause​​(and​​other​​than​​as​ ​result​ ​of​ ​death​ ​or​​disability)​​or​​due​​to​​your​​resignation​​for​​Good​​Reason​​(collectively,​​an​​“Involuntary​​Termination”),​ ​then​ ​provided​ ​such​ ​Involuntary​ ​Termination​ ​constitutes​ ​a​ ​“separation​ ​from​ ​service”​ ​(as​ ​defined​ ​under​ ​Treasury​ ​Regulation​​Section​​1.409A-1(h),​​without​​regard​​to​​any​​alternative​​definition​​thereunder,​​a​​“Separation​​from​​Service”),​ ​and​​provided​​that​​you​​remain​​in​​compliance​​with​​the​​terms​​of​​this​​Agreement,​​the​​Company​​will​​provide​​you​​with​​the​ ​following​ ​severance​ ​benefits​ ​(collectively,​ ​the​ ​“Severance​​Benefits”):​​(a)​​an​​amount​​equal​​to​​twelve​​(12)​​months​​of​ ​your​ ​then-current​ ​base​ ​salary​ ​to​ ​be​ ​paid​​in​​equal​​installments​​on​​the​​Company’s​​normal​​payroll​​schedule​​over​​the​ ​twelve​​(12)​​month​​period​​immediately​​following​​the​​date​​of​​Separation​​from​​Service;​​and​​(b)​​provided​​that​​you​​timely​ ​elect​ ​continued​ ​coverage​ ​under​ ​COBRA,​​the​​Company​​will​ ​pay​​your​​COBRA​​premiums​​to​​continue​​your​​coverage​ ​(including​ ​coverage​ ​for​ ​eligible​ ​dependents,​ ​if​ ​applicable)​ ​(“COBRA​ ​Premiums”)​ ​through​ ​the​ ​period​ ​(the​ ​“COBRA​ ​Premium​​Period”)​​starting​​on​​your​​Separation​​from​​Service​​date​​and​​ending​​on​​the​​earliest​​to​​occur​​of:​​(i)​​twelve​​(12)​ ​months​​following​​your​​Separation​​from​​Service;​​(ii)​​the​​date​​you​​become​​eligible​​for​​group​​health​​insurance​​coverage​ ​through​​a​​new​​employer;​​or​​(iii)​​the​​date​​you​​cease​​to​​be​​eligible​​for​​COBRA​​continuation​​coverage​​for​​any​​reason,​ ​including​ ​plan​ ​termination.​ ​In​ ​the​ ​event​ ​you​ ​become​ ​covered​ ​under​ ​another​ ​employer's​ ​group​ ​health​ ​plan​ ​or​ ​otherwise​ ​cease​ ​to​ ​be​ ​eligible​ ​for​ ​COBRA​ ​during​ ​the​ ​COBRA​ ​Premium​ ​Period,​ ​you​ ​must​ ​immediately​ ​notify​ ​the​ ​Company​ ​of​ ​such​ ​event.​ ​Notwithstanding​ ​the​ ​foregoing,​ ​if​ ​the​ ​Company​ ​determines,​ ​in​ ​its​ ​sole​ ​discretion,​ ​that​ ​it​ ​cannot​​pay​​the​​COBRA​​Premiums​​without​​a​​substantial​​risk​​of​​violating​​applicable​​law​​(including,​​without​​limitation,​ ​Section​ ​2716​ ​of​ ​the​ ​Public​ ​Health​ ​Service​ ​Act),​ ​the​ ​Company​ ​will​ ​in​​lieu​​thereof​​provide​​to​​you​​a​​taxable​​monthly​ ​payment​ ​in​ ​an​ ​amount​ ​equal​ ​to​ ​the​ ​monthly​ ​COBRA​ ​premium​​that​​you​​would​​be​​required​​to​​pay​​to​​continue​​your​ ​group​ ​health​ ​coverage​ ​in​ ​effect​ ​on​ ​the​ ​date​ ​of​ ​your​ ​employment​ ​termination​ ​(which​ ​amount​ ​will​ ​be​​based​​on​​the​ ​premium​ ​for​ ​the​ ​first​ ​month​ ​of​ ​COBRA​ ​coverage),​ ​which​ ​payments​ ​will​ ​be​ ​made​ ​on​ ​the​ ​last​ ​day​ ​of​ ​each​ ​month​ ​regardless​​of​​whether​​you​​elect​​COBRA​​continuation​​coverage​​and​​will​​end​​on​​the​​earlier​​of​​(x)​​the​​date​​upon​​which​ ​you​ ​obtain​ ​other​ ​employment​ ​or​​(y)​​the​​last​​day​​of​​the​​12​​th​ ​calendar​​month​​following​​your​​Separation​​from​​Service​ ​date.​ ​If​ ​your​ ​Involuntary​ ​Termination​ ​occurs​ ​either​ ​in​​connection​​with​​a​​Change​​in​​Control​​(as​​defined​​in​​the​​Company’s​ ​2016​​Equity​​Incentive​​Plan),​​or​​within​​3​​months​​prior​​to​​or​​within​​twelve​​(12)​​months​​following​​the​​closing​​of​​a​​Change​ ​in​​Control,​​and​​such​​termination​​qualifies​​as​​a​​Separation​​from​​Service,​​and​​provided​​that​​you​​remain​​in​​compliance​ ​with​ ​the​ ​terms​ ​of​ ​this​ ​Agreement,​ ​then​ ​you​ ​will​ ​be​ ​entitled​ ​to​​the​​Severance​​Benefits​​provided​​for​​above,​​and​​the​ ​following​ ​additional​ ​benefits:​ ​(a)​ ​an​​amount​​equal​​to​​twelve​​(12)​​months​​of​​your​​then-current​​“cash​​eligible”​​annual​ ​target​​bonus​​to​​be​​paid​​in​​equal​​installments​​on​​the​​Company’s​​normal​​payroll​​schedule​​over​​the​​twelve​​(12)​​month​ ​period​ ​immediately​ ​following​ ​the​ ​date​ ​of​ ​Separation​ ​from​ ​Service,​ ​which,​ ​for​ ​the​ ​avoidance​ ​of​ ​doubt,​ ​shall​ ​be​ ​in​ ​addition​​to​​payment​​of​​(i)​​any​​earned​​but​​unpaid​​annual​​bonus​​for​​the​​fiscal​​year​​preceding​​the​​fiscal​​year​​in​​which​ ​such​​Separation​​from​​Service​​occurs​​based​​on​​actual​​performance,​​as​​determined​​by​​the​​Compensation​​Committee​ ​and​ ​(ii)​ ​an​ ​annual​ ​bonus​ ​for​ ​the​ ​fiscal​ ​year​ ​in​ ​which​ ​the​​Separation​​from​​Service​​occurs,​​prorated​​to​​your​​date​​of​ ​Separation​​from​​Service​​and​​determined​​based​​on​​the​​greater​​of​​target​​performance​​or​​actual​​performance​​as​​of​​your​ ​date​ ​of​ ​Separation​ ​from​ ​Service​​,​ ​as​ ​determined​ ​by​ ​the​ ​Compensation​ ​Committee​​;​ ​(b)​ ​100%​ ​of​ ​all​ ​of​ ​your​ ​then-outstanding​ ​time-based​ ​unvested​ ​Company​ ​equity​ ​awards​ ​will​ ​accelerate​ ​and​ ​will​ ​be​ ​deemed​ ​vested​ ​and​ Exhibit 10.2

 
​exercisable​ ​(if​ ​applicable)​ ​as​​of​​your​​date​​of​​Separation​​from​​Service;​​and​​(c)​​100%​​of​​all​ ​of​​your​​then-outstanding​ ​performance-based​​unvested​​Company​​equity​​awards​​will​ ​accelerate​​and​​will​ ​be​​deemed​​vested​​and​​exercisable​​(if​ ​applicable)​​based​​on​​the​​greater​​of​​your​​target​​performance​​rate​​or​​actual​​performance​​as​​of​​your​​date​​of​​Separation​ ​from​ ​Service​​(collectively,​​the​​“Change​​in​​Control​​Severance​​Benefits”),​​including​​any​​performance-based​​unvested​ ​awards​ ​granted​ ​pursuant​ ​to​ ​the​ ​Company’s​ ​Senior​ ​Leadership​ ​Equity​ ​Bonus​ ​Program​ ​(or​ ​similar​ ​annual​ ​bonus​ ​program​ ​that​ ​may​ ​be​ ​adopted​ ​in​ ​the​​future)​​(an​​“Equity​​Bonus​​Program”).​​For​​the​​avoidance​​of​​doubt,​​if​ ​you​​have​ ​elected​ ​to​ ​receive​ ​your​ ​annual​ ​bonus​ ​in​ ​equity​ ​in​ ​lieu​ ​of​ ​cash​ ​pursuant​ ​to​ ​an​ ​Equity​ ​Bonus​ ​Program,​ ​and​ ​have​ ​received​ ​an​ ​equity​ ​grant​ ​as​ ​a​ ​result​ ​of​ ​this​ ​election,​ ​your​ ​annual​ ​bonus​ ​for​​the​​performance​​period​​for​​which​​you​ ​made​ ​the​ ​election​ ​will​ ​no​ ​longer​ ​be​ ​considered​ ​“cash-eligible”​ ​for​ ​purposes​ ​of​ ​subsection​ ​(a)​ ​of​ ​this​ ​paragraph;​ ​provided​ ​however,​ ​that​ ​for​ ​any​ ​period​ ​for​ ​which​​you​​have​​elected​​to​​receive​​your​​annual​​bonus​​in​​equity​​in​​lieu​​of​ ​cash​​pursuant​​to​​an​​Equity​​Bonus​​Program,​​and​​for​​which​​the​​Company​​has​​not​​yet​​granted​​an​​equity​​award​​to​​you​ ​as​​of​​the​​date​​of​​Separation​​of​​Service,​​then​​such​​election​​shall​​be​​void,​​and​​your​​annual​​bonus​​for​​such​​period​​shall​ ​be “cash-eligible” in accordance with subsection (a) of this paragraph.​ ​The​​receipt​​of​​the​​Severance​​Benefits​​or​​the​​Change​​in​​Control​​Severance​​Benefits,​​as​​applicable,​​provided​​above​ ​will​ ​be​​subject​​to​​you​​signing​​and​​not​​revoking​​a​​separation​​agreement​​and​​release​​of​​claims​​in​​a​​form​​similar​​to​​that​ ​attached​​hereto​​as​​Exhibit​​A​​(as​​amended​​to​​reflect​​the​​reason​​for​​the​​separation​​and​​any​​changes​​to​​the​​law)​​(the​ ​“Separation​​Agreement”)​​within​​the​​time​​period​​set​​forth​​therein,​​which​​will​​not​​exceed​​50​​days​​from​​the​​date​​of​​your​ ​Separation​​from​​Service​​(the​​“Release​​Period”).​​No​​Severance​​Benefits​​or​​Change​​in​​Control​​Severance​​Benefits,​​as​ ​applicable,​ ​will​ ​be​ ​paid​ ​or​ ​provided​ ​until​ ​the​ ​Separation​ ​Agreement​ ​becomes​ ​effective.​ ​If​ ​the​ ​Release​ ​Period​ ​described​ ​in​ ​the​ ​preceding​ ​sentence​ ​spans​ ​two​ ​calendar​ ​years,​ ​then​ ​payment​ ​of​ ​the​ ​Severance​ ​Benefits​ ​or​ ​the​ ​Change​​in​​Control​​Severance​​Benefits,​​as​​applicable,​​will​ ​in​​any​​event​​commence​​in​​the​​second​​calendar​​year.​​You​ ​will​ ​also​​resign​​from​​all​​positions​​and​​terminate​​any​​relationships​​as​​an​​employee,​​advisor,​​officer​​or​​director​​with​​the​ ​Company and any of its affiliates, each effective on the date of termination.​ ​For​ ​purposes​ ​of​ ​this​ ​Agreement,​ ​“Cause”​ ​will​ ​mean​ ​termination​ ​based​ ​upon​ ​(i)​ ​your​ ​willful​ ​failure​ ​to​ ​follow​​lawful​ ​directions​ ​communicated​​to​​you​​by​​the​​Board​​or​​otherwise​​to​​perform​​your​​duties​​to​​the​​Company;​​(ii)​​the​​willful​​or​ ​intentional​ ​engaging​ ​by​ ​you​ ​in​ ​conduct​ ​which​ ​is​ ​injurious​ ​to​ ​the​ ​Company​ ​or​ ​its​ ​reputation,​ ​business​​or​​business​ ​relationships,​​monetarily​​or​​otherwise;​​(iii)​​your​​commission​​of​​an​​act​​of​​fraud,​​misappropriation​​or​​embezzlement​​with​ ​respect​​to​​the​​Company​​or​​the​​Company's​​business;​​(iv)​​your​​conviction​​of,​​or​​a​​plea​​of​​guilty​​or​​nolo​​contendere​​to,​​a​ ​felony​​or​​a​​crime​​of​​moral​​turpitude​​(meaning​​an​​extreme​​departure​​from​​ordinary​​standards​​of​​honesty,​​good​​morals,​ ​justice​​or​​ethics​​as​​to​​be​​shocking​​in​​the​​moral​​sense​​of​​community);​​(v)​​your​​habitual​​drunkenness​​or​​use​​of​​illegal​ ​substances;​​(vi)​​a​​material​​breach​​by​​you​​of​​your​​obligations​​under​​this​​Agreement,​​including​​(without​​limitation)​​your​ ​obligations​ ​specified​ ​in​ ​your​​Employee​​Invention​​Assignment​​Agreement,​​Confidentiality​​and​​Arbitration​​Agreement​ ​that​ ​is​ ​not​ ​cured​ ​(to​ ​the​ ​extent​ ​curable)​ ​within​ ​15​ ​days​ ​of​ ​the​ ​Company​ ​providing​ ​written​ ​notice​ ​of​ ​such​​material​ ​breach;​​or​​(vii)​​your​​commission​​of​​an​​act​​of​​gross​​neglect​​or​​gross​​misconduct​​in​​connection​​with​​the​​performance​​of​ ​your duties.​ ​For​ ​purposes​​of​​this​​Agreement,​​“Good​​Reason”​​means​​the​​occurrence​​of​​one​​of​​the​​following​​events​​without​​your​ ​written​​consent:​​(i)​​a​​material​​diminution​​by​​the​​Company​​in​​your​​title​​or​​the​​nature​​or​​scope​​of​​your​​responsibilities,​ ​duties​​or​​authority​​with​​the​​Company,​​it​​being​​specified​​that​​no​​longer​​holding​​the​​office​​of​​Chief​​Executive​​Officer​​of​​a​ ​publicly​​traded​​company​​will​​be​​considered​​a​​material​​diminution​​in​​responsibilities​​under​​this​​clause​​(i),​​(ii)​​a​​material​ ​reduction​ ​of​ ​your​ ​base​ ​salary,​ ​(iii)​ ​a​ ​relocation​ ​of​ ​your​ ​principal​​place​​of​​employment​​that​​increases​​your​​one-way​ ​commute​ ​by​ ​more​ ​than​ ​50​ ​miles​ ​as​ ​compared​ ​to​ ​your​ ​then-current​ ​principal​ ​place​ ​of​ ​employment​ ​prior​ ​to​ ​such​ ​relocation​ ​(it​ ​being​ ​understood​ ​that​ ​you​ ​are​ ​expected​ ​to​ ​spend​ ​material​ ​amounts​ ​of​ ​time​ ​in​ ​the​ ​Company’s​​other​ ​offices​ ​as​​part​​of​​your​​duties​​hereunder),​​or​​(iv)​​failure​​by​​the​​Company​​to​​ensure​​that​​a​​successor​​entity​​assumes​ ​this​ ​Agreement;​ ​provided,​ ​however,​ ​that​ ​to​ ​resign​ ​for​ ​Good​ ​Reason,​ ​you​ ​must​ ​(1)​ ​provide​ ​written​ ​notice​ ​to​ ​the​ ​Company’s​​General​​Counsel​​within​​30​​days​​after​​the​​first​​occurrence​​of​​the​​event​​giving​​rise​​to​​Good​​Reason​​setting​ ​forth​​the​​basis​​for​​your​​resignation,​​(2)​​allow​​the​​Company​​at​​least​​30​​days​​from​​receipt​​of​​such​​written​​notice​​to​​cure​ ​such​ ​event,​ ​and​ ​(3)​ ​if​ ​such​ ​event​​is​​not​​reasonably​​cured​​with​​such​​period,​​your​​resignation​​from​​all​​positions​​you​ ​then hold with the Company is effective not later than 60 days after the expiration of the cure period.​ ​Benefits​ ​As​​a​​regular​​full-time​​employee,​​you​​will​​continue​​to​​be​​eligible​​to​​participate​​in​​Company-sponsored​​medical,​​dental,​ ​vision,​​life​​insurance,​​short​​and​​long-term​​disability​​plans.​​The​​Company​​may​​discontinue​​or​​modify​​any​​such​​plans,​ ​programs or practices at any time, with or without notice.​ Exhibit 10.2

 
​Section 280G​ ​If​​any​​payment​​or​​benefit​​(including​​payments​​and​​benefits​​pursuant​​to​​this​​Agreement)​​that​​you​​would​​receive​​from​ ​the​​Company​​or​​otherwise​​in​​connection​​with​​a​​Change​​in​​Control​​(the​​“Transaction​​Payment”)​​would​​(i)​​constitute​​a​ ​“parachute​ ​payment”​ ​within​ ​the​​meaning​​of​​Section​​280G​​of​​the​​Internal​​Revenue​​Code​​of​​1986,​​as​​amended​​(the​ ​“Code”)​​and​​(ii)​​but​​for​​this​​sentence,​​be​​subject​​to​​the​​excise​​tax​​imposed​​by​​Section​​4999​​of​​the​​Code​​(the​​“Excise​ ​Tax”),​ ​then​ ​the​ ​Company​​will​ ​cause​​to​​be​​determined,​​before​​any​​amounts​​of​​the​​Transaction​​Payment​​are​​paid​​to​ ​you,​​which​​of​​the​​following​​two​​alternative​​forms​​of​​payment​​would​​result​​in​​your​​receipt,​​on​​an​​after-tax​​basis,​​of​​the​ ​greater​​amount​​of​​the​​Transaction​​Payment​​notwithstanding​​that​​all​​or​​some​​portion​​of​​the​​Transaction​​Payment​​may​ ​be​​subject​​to​​the​​Excise​​Tax:​​(1)​​payment​​in​​full​ ​of​​the​​entire​​amount​​of​​the​​Transaction​​Payment​​(a​​“Full​​Payment”),​ ​or​​(2)​​payment​​of​​only​​a​​part​​of​​the​​Transaction​​Payment​​so​​that​​you​​receive​​the​​largest​​payment​​possible​​without​​the​ ​imposition​​of​​the​​Excise​​Tax​​(a​​“Reduced​​Payment”).​​For​​purposes​​of​​determining​​whether​​to​​make​​a​​Full​​Payment​​or​ ​a​​Reduced​​Payment,​​the​​Company​​will​ ​cause​​to​​be​​taken​​into​​account​​all​​applicable​​federal,​​state​​and​​local​​income​ ​and​​employment​​taxes​​and​​the​​Excise​​Tax​​(all​​computed​​at​​the​​highest​​applicable​​marginal​​rate,​​net​​of​​the​​maximum​ ​reduction​ ​in​ ​federal​ ​income​ ​taxes​ ​which​ ​could​ ​be​ ​obtained​ ​from​ ​a​ ​deduction​ ​of​ ​such​ ​state​ ​and​ ​local​ ​taxes).​ ​If​ ​a​ ​Reduced​ ​Payment​ ​is​ ​made,​ ​(x)​ ​you​ ​will​ ​have​ ​no​​rights​​to​​any​​additional​​payments​​and/or​​benefits​​constituting​​the​ ​Transaction​ ​Payment,​ ​and​ ​(y)​ ​reduction​ ​in​ ​payments​ ​and/or​ ​benefits​ ​will​ ​occur​ ​in​ ​the​ ​manner​ ​that​ ​results​ ​in​ ​the​ ​greatest​​economic​​benefit​​to​​you​​as​​determined​​in​​this​​paragraph.​​If​​more​​than​​one​​method​​of​​reduction​​will​​result​​in​ ​the​ ​same​ ​economic​ ​benefit,​ ​the​ ​portions​ ​of​​the​​Transaction​​Payment​​will​ ​be​​reduced​​pro​​rata.​​Unless​​you​​and​​the​ ​Company​ ​otherwise​ ​agree​ ​in​ ​writing,​ ​any​ ​determination​ ​required​ ​under​ ​this​ ​section​ ​will​ ​be​​made​​in​​writing​​by​​the​ ​Company’s​​independent​​public​​accountants​​(the​​“Accountants”),​​whose​​determination​​will​​be​​conclusive​​and​​binding​ ​upon​ ​you​ ​and​ ​the​ ​Company​​for​​all​ ​purposes.​​For​​purposes​​of​​making​​the​​calculations​​required​​by​​this​​section,​​the​ ​Accountants​ ​may​ ​make​ ​reasonable​ ​assumptions​​and​​approximations​​concerning​​applicable​​taxes​​and​​may​​rely​​on​ ​reasonable,​ ​good​ ​faith​​interpretations​​concerning​​the​​application​​of​​Sections​​280G​​and​​4999​​of​​the​​Code.​​You​​and​ ​the​ ​Company​ ​will​ ​furnish​ ​to​ ​the​​Accountants​​such​​information​​and​​documents​​as​​the​​Accountants​​may​​reasonably​ ​request​ ​in​​order​​to​​make​​a​​determination​​under​​this​​section.​​The​​Company​​will​ ​bear​​all​ ​costs​​the​​Accountants​​may​ ​reasonably​ ​incur​ ​in​ ​connection​ ​with​​any​​calculations​​contemplated​​by​​this​​section​​as​​well​​as​​any​​costs​​incurred​​by​ ​you with the Accountants for tax planning under Sections 280G and 4999 of the Code.​ ​Section 409A​ ​It​ ​is​ ​intended​ ​that​ ​all​ ​of​ ​the​ ​severance​ ​benefits​ ​and​ ​other​ ​payments​ ​payable​ ​under​ ​this​ ​Agreement​​satisfy,​​to​​the​ ​greatest​​extent​​possible,​​the​​exemptions​​from​​the​​application​​of​​Section​​409A​​of​​the​​Code​​(“Section​​409A”)​​provided​ ​under​​Treasury​​Regulations​​1.409A-1(b)(4),​​1.409A-1(b)(5)​​and​​1.409A-1(b)(9),​​and​​this​​Agreement​​will​​be​​construed​ ​to​​the​​greatest​​extent​​possible​​as​​consistent​​with​​those​​provisions,​​and​​to​​the​​extent​​not​​so​​exempt,​​this​​Agreement​ ​(and​ ​any​ ​definitions​ ​hereunder)​ ​will​ ​be​ ​construed​ ​in​ ​a​ ​manner​ ​that​ ​complies​ ​with​ ​Section​ ​409A.​ ​For​ ​purposes​ ​of​ ​Section​​409A​​(including,​​without​​limitation,​​for​​purposes​​of​​Treasury​​Regulation​​Section​​1.409A-2(b)(2)(iii)),​​your​​right​ ​to​ ​receive​ ​any​ ​installment​ ​payments​ ​under​ ​this​ ​Agreement​ ​(whether​ ​severance​ ​payments,​ ​reimbursements​ ​or​ ​otherwise)​ ​will​ ​be​ ​treated​ ​as​ ​a​ ​right​ ​to​ ​receive​ ​a​ ​series​ ​of​ ​separate​ ​payments​ ​and,​ ​accordingly,​ ​each​ ​installment​ ​payment​​hereunder​​will​ ​at​​all​ ​times​​be​​considered​​a​​separate​​and​​distinct​​payment.​​Notwithstanding​​any​​provision​​to​ ​the​​contrary​​in​​this​​Agreement,​​if​ ​you​​are​​deemed​​by​​the​​Company​​at​​the​​time​​of​​your​​Separation​​from​​Service​​to​​be​ ​a​ ​“specified​ ​employee”​ ​for​ ​purposes​ ​of​ ​Section​ ​409A(a)(2)(B)(i),​​and​​if​​any​​of​​the​​payments​​upon​​Separation​​from​ ​Service​ ​set​ ​forth​ ​herein​ ​and/or​ ​under​ ​any​ ​other​ ​agreement​ ​with​ ​the​ ​Company​ ​are​ ​deemed​ ​to​ ​be​ ​“deferred​ ​compensation”,​ ​then​ ​to​ ​the​ ​extent​​delayed​​commencement​​of​​any​​portion​​of​​such​​payments​​is​​required​​in​​order​​to​ ​avoid​ ​a​ ​prohibited​​distribution​​under​​Section​​409A(a)(2)(B)(i)​​and​​the​​related​​adverse​​taxation​​under​​Section​​409A,​ ​such​​payments​​will​ ​not​​be​​provided​​to​​you​​prior​​to​​the​​earliest​​of​​(i)​​the​​expiration​​of​​the​​six-month​​period​​measured​ ​from​​the​​date​​of​​your​​Separation​​from​​Service​​with​​the​​Company,​​(ii)​​the​​date​​of​​your​​death​​or​​(iii)​​such​​earlier​​date​​as​ ​permitted​ ​under​ ​Section​ ​409A​ ​without​​the​​imposition​​of​​adverse​​taxation.​​Upon​​the​​first​​business​​day​​following​​the​ ​expiration​​of​​such​​time​​period,​​all​ ​payments​​deferred​​pursuant​​to​​this​​section​​will​ ​be​​paid​​in​​a​​lump​​sum​​to​​you,​​and​ ​any​​remaining​​payments​​due​​will​​be​​paid​​as​​otherwise​​provided​​herein​​or​​in​​the​​applicable​​agreement.​​No​​interest​​will​ ​be​ ​due​ ​on​ ​any​ ​amounts​ ​so​ ​deferred.​ ​Notwithstanding​ ​anything​ ​to​ ​the​ ​contrary​ ​in​ ​this​ ​Agreement,​ ​all​ ​(1)​ ​reimbursements​​and​​(2)​​in-kind​​benefits​​provided​​under​​this​​Agreement​​shall​​be​​made​​or​​provided​​in​​accordance​​with​ ​the​ ​requirements​ ​of​ ​Section​ ​409A,​ ​including,​ ​where​ ​applicable,​ ​the​ ​requirement​ ​that​ ​(x)​ ​the​ ​amount​ ​of​ ​expenses​ ​eligible​​for​​reimbursement,​​or​​in​​kind​​benefits​​provided,​​during​​a​​calendar​​year​​may​​not​​affect​​the​​expenses​​eligible​ ​for​​reimbursement,​​or​​in​​kind​​benefits​​to​​be​​provided,​​in​​any​​other​​calendar​​year;​​(y)​​the​​reimbursement​​of​​an​​eligible​ ​expense​ ​will​ ​be​ ​made​ ​no​ ​later​ ​than​ ​the​ ​last​ ​day​ ​of​ ​the​ ​calendar​ ​year​ ​following​ ​the​ ​year​ ​in​ ​which​ ​the​​expense​​is​ ​incurred;​ ​and​ ​(z)​​the​​right​​to​​reimbursement​​or​​in​​kind​​benefits​​is​​not​​subject​​to​​liquidation​​or​​exchange​​for​​another​ ​benefit.​ ​In​ ​no​ ​event​ ​whatsoever​ ​will​ ​the​ ​Company​ ​be​ ​liable​ ​for​ ​any​ ​additional​​tax,​​interest​​or​​penalty​​that​​may​​be​ ​imposed on you by Section 409A or damages for failing to comply with Section 409A.​ Exhibit 10.2

 
​Arbitration​ ​You​​and​​the​​Company​​have​​previously​​executed​​the​​Company’s​​standard​​arbitration​​agreement​​that​​is​​contained​​in​ ​your​​Employee​​Invention​​Assignment,​​Confidentiality​​and​​Arbitration​​Agreement​​(the​​“Arbitration​​Agreement”),​​which​ ​agreement​ ​remains​ ​in​ ​full​ ​force​ ​and​ ​effect.​ ​You​ ​acknowledge​ ​and​ ​agree​ ​to​ ​all​ ​of​ ​the​​Company’s​​policies​​in​​effect​ ​during​ ​your​ ​employment​ ​with​ ​Company,​ ​including,​​but​​not​​limited​​to,​​the​​policies​​found​​in​​the​​MongoDB​​Employee​ ​Handbook and the Arbitration Agreement.​ ​At Will Employment​ ​Your​​employment​​relationship​​with​​the​​Company​​is​​“at-will."​​That​​means​​you​​are​​free,​​at​​any​​time,​​for​​any​​reason,​​to​ ​end​ ​your​ ​employment​ ​with​ ​the​ ​Company​ ​and​ ​that​ ​the​ ​Company​ ​may​ ​do​ ​the​ ​same.​ ​Our​ ​agreement​ ​regarding​ ​employment-at-will may not be changed, except specifically in writing signed by the Board and you.​ ​We look forward to your continued contributions to the growth and success of MongoDB over the coming years.​ ​Sincerely,​ ​MongoDB, Inc.​ ​Name: Andrew Stephens​ ​Date​ ​Title: General Counsel​ ​I hereby acknowledge my acceptance of continued employment with MongoDB pursuant to the terms and conditions​ ​contained in this Agreement.​ ​Chirantan J. Desai​ ​Date​ Exhibit 10.2 /s/ Andrew Stephens October 29, 2025 /s/ Chirantan Desai October 29, 2025

 
​Exhibit A​ ​[DATE]​ ​CJ Desai​ ​Re:​​Terms of​​[Resignation or Separation]​ ​This​​letter​​confirms​​the​​agreement​​(“Agreement”)​​between​​you​​and​​MongoDB,​​Inc.​​(the​​“Company”)​​concerning​​the​ ​terms​​of​​your​​[resignation​​or​​separation]​​and​​offers​​you​​the​​separation​​compensation​​we​​discussed​​in​​exchange​​for​ ​a general release of claims and covenant not to sue.​ ​1.​​[​​Resignation​​or​​Separation]​ ​Date​​:​​is​​your​​last​​day​​of​​employment​​with​​the​​Company​​(the​​“​​[Resignation ​or Separation]​​Date”).​ ​2.​​Acknowledgment​​of​​Payment​​of​​Wages​​:​​On​​the​​next​​regularly​​scheduled​​pay​​day​​following​​the​​Separation ​Date,​​the​​Company​​will​​pay​​you​​an​​amount​​that​​represents​​all​​of​​your​​salary​​earned​​through​​the​​Separation​​Date.​​Per​ ​the​ ​Company’s​​flexible​​time​​off​​program,​​paid​​time​​off​​is​​not​​accrued​​and​​is​​therefore​​not​​paid​​out​​upon​​separation​ ​from​​the​​Company.​​You​​acknowledge​​that,​​prior​​to​​the​​execution​​of​​this​​Agreement,​​you​​were​​not​​entitled​​to​​receive​ ​any​ ​additional​ ​money​ ​from​ ​the​ ​Company,​ ​and​ ​that​​the​​only​​payments​​and​​benefits​​that​​you​​are​​entitled​​to​​receive​ ​from the Company in the future are those specified in this Agreement.​ ​3.​​Separation​ ​Compensation​​:​ ​In​ ​exchange​ ​for​ ​your​​agreement​​to​​the​​general​​release​​and​​waiver​​of​​claims ​and​​covenant​​not​​to​​sue​​set​​forth​​below​​and​​your​​other​​promises​​herein,​​the​​Company​​agrees​​to​​provide​​you​​with​​the​ ​[Severance​​Benefits​​/​​Change​​in​​Control​​Severance​​Benefits]​​(as​​defined​​in​​the​​Offer​​Letter,​​dated​​as​​of​​October​ ​29, 2025, between you and the Company).​ ​By​ ​signing​ ​below,​ ​you​ ​acknowledge​ ​that​ ​you​ ​are​ ​receiving​ ​the​ ​separation​ ​compensation​ ​outlined​ ​in​ ​this​ ​paragraph​ ​in​ ​consideration​ ​for​ ​waiving​ ​your​ ​rights​ ​to​ ​claims​ ​referred​ ​to​ ​in​ ​this​ ​Agreement​​and​​that​​you​​would​​not​ ​otherwise be entitled to the separation compensation.​ ​4.​​Return​​of​​Company​​Property​​:​​You​​hereby​​warrant​​to​​the​​Company​​that​​you​​have​​returned​​to​​the​​Company ​all property or data of the Company of any type whatsoever that has been in your possession or control.​ ​5.​​Proprietary​​Information:​​You​​hereby​​acknowledge​​that​​you​​are​​and​​continue​​to​​be​​bound​​by​​the​​attached ​Employee​​Invention​​Assignment,​​Confidentiality​​and​​Arbitration​​Agreement​​(​​Exhibit​​A​​hereto)​​and​​that​​as​​a​​result​​of​ ​your​ ​employment​ ​with​ ​the​​Company​​you​​have​​had​​access​​to​​the​​Company’s​​Proprietary​​Information​​(as​​defined​​in​ ​the​​agreement),​​that​​you​​will​ ​hold​​all​ ​Proprietary​​Information​​in​​strictest​​confidence​​and​​that​​you​​will​​not​​make​​use​​of​ ​such​ ​Proprietary​ ​Information​ ​on​ ​behalf​ ​of​ ​anyone.​ ​You​ ​further​ ​confirm​​that​​you​​have​​delivered​​to​​the​​Company​​all​ ​documents​ ​and​ ​data​ ​of​ ​any​ ​nature​ ​containing​ ​or​ ​pertaining​ ​to​ ​such​​Proprietary​​Information​​and​​that​​you​​have​​not​ ​taken with you any such documents or data or any reproduction thereof.​ ​6.​​Equity​​:​ ​Pursuant​ ​to​ ​your​ ​award​ ​agreements​ ​with​ ​the​ ​Company​ ​dated​ ​[_____________]​ ​and​ ​the ​Company's​ ​2016​​Equity​​Incentive​​Plan​​(hereafter​​collectively​​referred​​to​​as​​the​​“Award​​Agreements”),​​you​​received​ ​certain​ ​equity​ ​awards.​ ​Your​ ​rights​ ​concerning​ ​any​ ​equity​ ​awards​ ​will​ ​be​ ​governed​ ​by​ ​the​ ​applicable​ ​Award​ ​Agreements, except as otherwise set forth in your Offer Letter.​ ​7.​​General Release and Waiver of Claims​​: ​a. ​The​ ​payments​ ​and​ ​promises​ ​set​ ​forth​ ​in​ ​this​​Agreement​​are​​in​​full​ ​satisfaction​​of​​all​ ​accrued ​salary,​​vacation​​pay,​​bonus​​and​​commission​​pay,​​profit-sharing,​​stock,​​stock​​options​​or​​other​​ownership​​interest​​in​​the​ Exhibit 10.2

 
​Company,​​termination​​benefits​​or​​other​​compensation​​to​​which​​you​​may​​be​​entitled​​by​​virtue​​of​​your​​employment​​with​ ​the​ ​Company​​or​​your​​separation​​from​​the​​Company.​​To​​the​​fullest​​extent​​permitted​​by​​law,​​you​​hereby​​release​​and​ ​waive​ ​any​ ​other​ ​claims​ ​you​ ​may​ ​have​ ​against​ ​the​ ​Company​ ​and​ ​its​ ​owners,​ ​agents,​ ​officers,​ ​shareholders,​ ​employees,​ ​directors,​ ​attorneys,​ ​subscribers,​ ​subsidiaries,​ ​affiliates,​ ​successors​ ​and​ ​assigns​ ​(collectively​ ​“Releasees”),​ ​whether​ ​known​ ​or​ ​not​ ​known,​ ​including,​ ​without​ ​limitation,​ ​claims​ ​under​ ​any​ ​employment​ ​laws,​ ​including,​​but​​not​​limited​​to,​​claims​​of​​unlawful​​discharge,​​breach​​of​​contract,​​breach​​of​​the​​covenant​​of​​good​​faith​​and​ ​fair​ ​dealing,​ ​fraud,​ ​violation​ ​of​ ​public​ ​policy,​ ​defamation,​ ​physical​ ​injury,​ ​emotional​ ​distress,​ ​claims​ ​for​ ​additional​ ​compensation​​or​​benefits​​arising​​out​​of​​your​​employment​​or​​your​​separation​​of​​employment,​​claims​​under​​Title​​VII​​of​ ​the​ ​1964​ ​Civil​ ​Rights​ ​Act,​ ​as​ ​amended,​ ​the​ ​New​ ​York​ ​Human​ ​Rights​ ​Law​ ​and​ ​any​ ​other​ ​laws​​and/or​​regulations​ ​relating​​to​​employment​​or​​employment​​discrimination,​​including,​​without​​limitation,​​claims​​based​​on​​age​​or​​under​​the​ ​Age​​Discrimination​​in​​Employment​​Act​​or​​Older​​Workers​​Benefit​​Protection​​Act,​​and/or​​claims​​based​​on​​disability​​or​ ​under the Americans with Disabilities Act.​ ​b. ​You​ ​hereby​ ​acknowledge​ ​that​ ​you​ ​are​ ​aware​ ​of​ ​the​ ​principle​ ​that​ ​a​​general​​release​​does​​not ​extend​​to​​claims​​that​​the​​releasor​​does​​not​​know​​or​​suspect​​to​​exist​​in​​his​​or​​her​​favor​​at​​the​​time​​of​​executing​​the​ ​release,​ ​which,​ ​if​ ​known​ ​by​ ​him​​or​​her,​​must​​have​​materially​​affected​​his​​or​​her​​settlement​​with​​the​​releasee.​​With​ ​knowledge of this principle, you hereby agree to expressly waive any rights you may have to that effect.​ ​You​​further​​acknowledge​​that​​you​​waive​​all​​rights​​afforded​​by​​Section​​1542​​of​​the​​Civil​​Code​​of​​the​ ​State​​of​​California​​(“Section​​1542”),​​or​​any​​other​​law​​or​​statute​​of​​similar​​effect​​in​​any​​jurisdiction​​with​​respect​​to​​the​ ​released Claims, with respect to the Releasees. Section 1542 states:​ ​“A​ ​GENERAL​ ​RELEASE​ ​DOES​ ​NOT​ ​EXTEND​ ​TO​ ​CLAIMS​ ​THAT​ ​THE​ ​CREDITOR​ ​OR​ ​RELEASING​ ​PARTY​ ​DOES​ ​NOT​ ​KNOW​ ​OR​ ​SUSPECT​ ​TO​​EXIST​​IN​​HIS​​OR​​HER​​FAVOR​​AT​ ​THE​​TIME​​OF​​EXECUTING​​THE​​RELEASE,​​THAT​​IF​​KNOWN​​BY​​HIM​​OR​​HER​​WOULD​​HAVE​ ​MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.”​ ​Notwithstanding​ ​the​ ​provisions​ ​of​ ​Section​ ​1542​ ​and​ ​for​ ​the​ ​purpose​ ​of​ ​implementing​ ​a​ ​full​ ​and​ ​complete​​release​​of​​all​ ​claims,​​you​​acknowledge​​and​​agree​​that​​this​​Agreement​​releases​​all​​claims​​existing​​or​​arising​ ​prior​​to​​your​​execution​​of​​this​​Agreement​​which​​you​​have​​or​​suspect​​you​​may​​have​​against​​the​​Releasees​​whether​ ​such​ ​claims​ ​are​ ​known​ ​or​ ​unknown​ ​and​​suspected​​or​​unsuspected​​by​​you​​and​​you​​forever​​waive​​all​ ​inquiries​​and​ ​investigations​​into​​any​​and​​all​​such​​claims.​ ​You​​understand​​and​​acknowledge​​that​​the​​significance​​and​​consequence​ ​of​​this​​waiver​​of​​Civil​ ​Code​​§1542,​​is​​that​​even​​if​​you​​should​​suffer​​additional​​injuries​​or​​damages​​arising​​out​​of​​the​ ​released claims, you will not be permitted to make any claim for those injuries or damages.​ ​c. ​You​​and​​the​​Company​​do​​not​​intend​​to​​release​​claims​​that​​you​​may​​not​​release​​as​​a​​matter​​of ​law,​​including​​but​​not​​limited​​to​​claims​​for​​indemnity,​​and​​any​​claims​​for​​enforcement​​of​​this​​Agreement.​​To​​the​​fullest​ ​extent​​permitted​​by​​law,​​any​​dispute​​regarding​​the​​scope​​of​​this​​general​​release​​shall​​be​​determined​​by​​an​​arbitrator​ ​under the procedures set forth in the arbitration clause below.​ ​8.​​Covenant Not to Sue​​: ​a. ​To​​the​​fullest​​extent​​permitted​​by​​law,​​at​​no​​time​​subsequent​​to​​the​​execution​​of​​this​​Agreement ​will​ ​you​ ​pursue,​ ​or​ ​cause​ ​or​ ​knowingly​ ​permit​ ​the​​prosecution,​​in​​any​​state,​​federal​​or​​foreign​​court,​​or​​before​​any​ ​local,​ ​state,​ ​federal​ ​or​ ​foreign​​administrative​​agency,​​or​​any​​other​​tribunal,​​any​​charge,​​claim​​or​​action​​of​​any​​kind,​ ​nature​​and​​character​​whatsoever,​​known​​or​​unknown,​​which​​you​​may​​now​​have,​​have​​ever​​had,​​or​​may​​in​​the​​future​ ​have against Releasees, which is based in whole or in part on any matter covered by this Agreement.​ ​b.Nothing​ ​in​ ​this​ ​section​ ​shall​ ​prohibit​ ​you​ ​from​ ​filing​ ​a​ ​charge​ ​or​ ​complaint​ ​with​ ​a​ ​government ​agency​ ​where,​ ​as​ ​a​ ​matter​ ​of​ ​law,​ ​the​ ​parties​ ​may​ ​not​ ​restrict​ ​your​ ​ability​ ​to​ ​file​ ​such​ ​administrative​ ​complaints.​ ​However,​ ​you​ ​understand​ ​and​​agree​​that,​​by​​entering​​into​​this​​Agreement,​​you​​are​​releasing​​any​​and​​all​​individual​ ​claims​​for​​relief,​​and​​that​​any​​and​​all​​subsequent​​disputes​​between​​you​​and​​the​​Company​​shall​​be​​resolved​​through​ ​arbitration as provided below.​ ​c.Nothing​ ​in​ ​this​ ​section​ ​shall​ ​prohibit​ ​or​ ​impair​ ​you​ ​or​ ​the​ ​Company​ ​from​ ​complying​ ​with​ ​all ​applicable​ ​laws,​ ​nor​ ​shall​ ​this​ ​Agreement​ ​be​ ​construed​ ​to​ ​obligate​ ​either​ ​party​ ​to​ ​commit​ ​(or​ ​aid​ ​or​ ​abet​ ​in​ ​the​ ​commission of) any unlawful act.​ ​9.​​Nondisparagement​​:​ ​You​​agree​​that​​you​​will​ ​not​​disparage​​Releasees​​or​​their​​products,​​services,​​agents, ​representatives,​​directors,​​officers,​​shareholders,​​attorneys,​​employees,​​vendors,​​affiliates,​​successors​​or​​assigns,​​or​ ​any​​person​​acting​​by,​​through,​​under​​or​​in​​concert​​with​​any​​of​​them,​​with​​any​​written​​or​​oral​​statement.​​Nothing​​in​​this​ Exhibit 10.2

 
​paragraph​ ​shall​ ​prohibit​ ​you​ ​from​ ​providing​ ​truthful​ ​information​ ​in​ ​response​ ​to​​a​​subpoena​​or​​other​​legal​​process.​ ​Notwithstanding​ ​the​ ​foregoing,​ ​nothing​ ​in​ ​this​​Agreement​​precludes​​or​​otherwise​​limits​​your​​ability​​to​​communicate​ ​directly​​with​​and​​provide​​information,​​including​​documents,​​not​​otherwise​​protected​​from​​disclosure​​by​​any​​applicable​ ​law​ ​or​ ​privilege​ ​to​ ​the​ ​Securities​ ​and​ ​Exchange​ ​Commission​ ​(the​ ​“SEC”),​ ​or​ ​any​ ​other​ ​federal,​ ​state​ ​or​ ​local​ ​governmental​​agency​​or​​commission​​or​​self-regulatory​​organization​​(each​​such​​agency,​​commission​​or​​organization,​ ​a​​“Government​​Agency”)​​or​​self-regulatory​​organization​​regarding​​possible​​legal​​violations,​​without​​disclosure​​to​​the​ ​Company.​​You​​do​​not​​need​​the​​prior​​authorization​​of​​the​​Company​​to​​make​​any​​such​​reports​​or​​disclosures,​​and​​you​ ​shall​​not​​be​​required​​to​​notify​​the​​Company​​that​​such​​reports​​or​​disclosures​​have​​been​​made.​​The​​Company​​may​​not​ ​retaliate​ ​against​ ​you​ ​for​ ​any​​of​​these​​activities,​​and​​nothing​​in​​this​​Agreement​​requires​​you​​to​​waive​​any​​monetary​ ​award or other relief that you might become entitled to from the SEC or any other Government Agency.​ ​10.​​Arbitration​​:​ ​Except​ ​for​ ​any​ ​claim​ ​for​ ​injunctive​ ​relief​ ​arising​ ​out​ ​of​ ​a​ ​breach​ ​of​ ​a​​party’s​​obligations​​to ​protect​​the​​other’s​​proprietary​​information,​​the​​parties​​agree​​to​​arbitrate,​​in​​County,​​New​​York,​​any​​and​​all​​disputes​​or​ ​claims​​arising​​out​​of​​or​​related​​to​​the​​validity,​​enforceability,​​interpretation,​​performance​​or​​breach​​of​​this​​Agreement,​ ​whether​​sounding​​in​​tort,​​contract,​​statutory​​violation​​or​​otherwise,​​or​​involving​​the​​construction​​or​​application​​or​​any​ ​of​​the​​terms,​​provisions,​​or​​conditions​​of​​this​​Agreement.​​Any​​arbitration​​may​​be​​initiated​​by​​a​​written​​demand​​to​​the​ ​other​ ​party.​ ​The​ ​arbitrator's​ ​decision​ ​shall​ ​be​ ​final,​ ​binding,​ ​and​ ​conclusive.​ ​The​ ​parties​ ​further​ ​agree​ ​that​ ​this​ ​Agreement​​is​​intended​​to​​be​​strictly​​construed​​to​​provide​​for​​arbitration​​as​​the​​sole​​and​​exclusive​​means​​for​​resolution​ ​of​​all​ ​disputes​​hereunder​​to​​the​​fullest​​extent​​permitted​​by​​law.​​The​​parties​​expressly​​waive​​any​​entitlement​​to​​have​ ​such controversies decided by a court or a jury.​ ​11.​​Attorneys’​​Fees​​:​​If​​any​​action​​is​​brought​​to​​enforce​​the​​terms​​of​​this​​Agreement,​​the​​prevailing​​party​​will ​be​​entitled​​to​​recover​​its​​reasonable​​attorneys’​​fees,​​costs​​and​​expenses​​from​​the​​other​​party,​​in​​addition​​to​​any​​other​ ​relief to which the prevailing party may be entitled.​ ​12.​​Confidentiality​​:​ ​Except​ ​as​ ​required​ ​by​ ​applicable​ ​law,​ ​the​ ​contents,​ ​terms​ ​and​ ​conditions​ ​of​ ​this ​Agreement​​must​​be​​kept​​confidential​​by​​you​​and​​may​​not​​be​​disclosed​​except​​to​​your​​immediate​​family,​​accountant​​or​ ​attorneys​ ​or​ ​pursuant​ ​to​ ​subpoena​ ​or​ ​court​ ​order.​ ​You​ ​agree​ ​that​ ​if​ ​you​​are​​asked​​for​​information​​concerning​​this​ ​Agreement,​​you​​will​ ​state​​only​​that​​you​​and​​the​​Company​​reached​​an​​amicable​​resolution​​of​​any​​disputes​​concerning​ ​your​​separation​​from​​the​​Company.​​Any​​breach​​of​​this​​confidentiality​​provision​​shall​​be​​deemed​​a​​material​​breach​​of​ ​this Agreement.​ ​13.​​No​​Admission​​of​​Liability​​:​​This​​Agreement​​is​​not​​and​​shall​​not​​be​​construed​​or​​contended​​by​​you​​to​​be​​an ​admission​​or​​evidence​​of​​any​​wrongdoing​​or​​liability​​on​​the​​part​​of​​Releasees,​​their​​representatives,​​heirs,​​executors,​ ​attorneys,​​agents,​​partners,​​officers,​​shareholders,​​directors,​​employees,​​subsidiaries,​​affiliates,​​divisions,​​successors​ ​or​​assigns.​​This​​Agreement​​shall​​be​​afforded​​the​​maximum​​protection​​allowable​​under​​the​​Federal​​Rules​​of​​Evidence​ ​408 and/or any other state or federal provisions of similar effect.​ ​14.​​Complete​ ​and​ ​Voluntary​ ​Agreement​​:​ ​This​ ​Agreement,​ ​together​ ​with​ ​Exhibit​ ​A​ ​hereto​ ​and​ ​any​ ​equity ​award​ ​agreements,​ ​constitute​ ​the​​entire​​agreement​​between​​you​​and​​Releasees​​with​​respect​​to​​the​​subject​​matter​ ​hereof​​and​​supersedes​​all​​prior​​negotiations​​and​​agreements,​​whether​​written​​or​​oral,​​relating​​to​​such​​subject​​matter.​ ​You​ ​acknowledge​ ​that​ ​neither​ ​Releasees​ ​nor​ ​their​ ​agents​ ​or​ ​attorneys​​have​​made​​any​​promise,​​representation​​or​ ​warranty​ ​whatsoever,​ ​either​ ​express​ ​or​ ​implied,​ ​written​ ​or​ ​oral,​ ​which​ ​is​ ​not​ ​contained​ ​in​ ​this​ ​Agreement​ ​for​ ​the​ ​purpose of inducing you to execute the Agreement, and you acknowledge that you have executed this Agreement in​ ​reliance​ ​only​ ​upon​ ​such​ ​promises,​ ​representations​ ​and​ ​warranties​ ​as​ ​are​ ​contained​ ​herein,​ ​and​ ​that​ ​you​ ​are​ ​executing this Agreement voluntarily, free of any duress or coercion.​ ​15.​​Severability​​:​​The​​provisions​​of​​this​​Agreement​​are​​severable,​​and​​if​​any​​part​​of​​it​​is​​found​​to​​be​​invalid​​or ​unenforceable,​ ​the​ ​other​ ​parts​ ​shall​ ​remain​ ​fully​ ​valid​ ​and​ ​enforceable.​ ​Specifically,​ ​should​ ​a​ ​court,​ ​arbitrator,​ ​or​ ​government​​agency​​conclude​​that​​a​​particular​​claim​​may​​not​​be​​released​​as​​a​​matter​​of​​law,​​it​​is​​the​​intention​​of​​the​ ​parties​ ​that​ ​the​ ​general​ ​release,​ ​the​ ​waiver​​of​​unknown​​claims​​and​​the​​covenant​​not​​to​​sue​​above​​shall​​otherwise​ ​remain effective to release any and all other claims.​ ​16.​​Modification;​​Counterparts;​​Facsimile/PDF​​Signatures​​:​​It​​is​​expressly​​agreed​​that​​this​​Agreement​​may​​not ​be​ ​altered,​ ​amended,​ ​modified,​ ​or​ ​otherwise​ ​changed​ ​in​ ​any​ ​respect​ ​except​ ​by​ ​another​ ​written​ ​agreement​ ​that​ ​specifically​​refers​​to​​this​​Agreement,​​executed​​by​​authorized​​representatives​​of​​each​​of​​the​​parties​​to​​this​​Agreement.​ ​This​​Agreement​​may​​be​​executed​​in​​any​​number​​of​​counterparts,​​each​​of​​which​​shall​​constitute​​an​​original​​and​​all​​of​ ​which​ ​together​ ​shall​ ​constitute​ ​one​ ​and​ ​the​​same​​instrument.​​Execution​​of​​a​​facsimile​​or​​PDF​​copy​​shall​​have​​the​ Exhibit 10.2

 
​same​ ​force​​and​​effect​​as​​execution​​of​​an​​original,​​and​​a​​copy​​of​​a​​signature​​will​ ​be​​equally​​admissible​​in​​any​​legal​ ​proceeding as if an original.​ ​17.​​Review​ ​of​ ​Separation​ ​Agreement​​:​ ​You​ ​understand​ ​that​ ​you​ ​may​ ​take​ ​up​ ​to​ ​twenty-one​ ​(21)​ ​days​ ​to ​consider​ ​this​ ​Agreement​ ​and,​ ​by​ ​signing​ ​below,​ ​affirm​ ​that​ ​you​ ​were​ ​advised​ ​to​ ​consult​ ​with​ ​an​ ​attorney​ ​prior​ ​to​ ​signing​ ​this​ ​agreement.​ ​You​ ​also​ ​understand​​you​​may​​revoke​​this​​Agreement​​within​​seven​​(7)​​days​​of​​signing​​this​ ​document​​and​​that​​the​​compensation​​to​​be​​paid​​to​​you​​pursuant​​to​​Paragraph​​3​​will​ ​be​​paid​​only​​at​​the​​end​​of​​that​ ​seven (7) day revocation period.​ ​18.​​Effective​​Date​​:​​This​​Agreement​​is​​effective​​on​​the​​eighth​​(8th)​​day​​after​​you​​sign​​it​​and​​without​​revocation ​by you.​ ​19.​​Governing​​Law​​:​​This​​Agreement​​shall​​be​​governed​​by​​and​​construed​​in​​accordance​​with​​the​​laws​​of​​the ​State of New York.​ ​If​ ​you​ ​agree​ ​to​ ​abide​ ​by​ ​the​ ​terms​ ​outlined​ ​in​ ​this​ ​letter,​ ​please​ ​sign​ ​this​ ​letter​ ​below​ ​and​ ​also​ ​sign​​the​ ​attached copy and return it to me. I wish you the best in your future endeavors.​ ​Sincerely,​ ​MongoDB, Inc.​ ​By: _______________________________​ ​[Name and title of person signing on behalf of the​ ​Company]​ ​READ, UNDERSTOOD AND AGREED​ ​CJ Desai: ____________________________ Date: _____________________________​ Exhibit 10.2

 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer